Revenue Protection for Specialty Infusion

Know what puts infusion revenue at risk—before it is lost.

Protect more revenue. Resolve the right issue first.

Assura identifies revenue risk across upcoming appointments and performed services, explains what is causing it, and gives your team the evidence and next action needed to resolve it. Built around the way your practice actually works.

Talk through your workflow → See how Assura works

Designed with specialty-provider operators.
Configured around your workflow.

Upcoming appointments · revenue at risk Rheumatology

{{ heroSel.name }} {{ heroSel.revenue }} at risk

DOB{{ heroSel.dob }}

Patient ID{{ heroSel.pid }}

Therapy{{ heroSel.drug }}

Scheduled{{ heroSel.date }} · {{ heroSel.time }}

Next {{ heroSel.action }}

{{ heroAssignInits }}Assigned · {{ heroAssignName }}

To be assigned

Open the full patient view →

Owner · {{ heroSel.owner }} · {{ heroSel.urgency }}

The work between referral and payment

Revenue risk hides in the gaps between systems.

Every infusion depends on a chain of decisions staying aligned: the referral, active coverage, benefit pathway, drug, site, dose, authorization, documentation, claim, and payer response.

Your team manages that chain across portals, calls, faxes, EHR queues, spreadsheets, and institutional knowledge. The work is not invisible because it is unimportant. It is invisible because the evidence lives in different places.

Referral → payment · where revenue is exposed Illustrative workflow

Missing note

Referral received

Inactive insurance

Coverage confirmed

Benefit path determined

Auth expires

Authorization aligned

Wrong biosimilar

Drug & site confirmed

Service performed

Units mismatch

Claim validated

Underpayment

Payer adjudicated

Revenue collected

Most teams find these issues in the order they appear. Assura ranks them in the order they matter.

From task volume to financial priority

See the revenue at risk across every upcoming appointment and unresolved claim.

Assura creates a live view of potential revenue exposure, then prioritizes each issue using revenue at risk, time until the appointment or filing deadline, expected time to resolve, practice-defined priority, and confidence in the detected issue.

Specialty

Assura · revenue at risk · {{ specLabel }} Illustrative

Prioritized by revenue at risk

{{ D.priority }}{{ D.date }} · {{ D.time }} · {{ D.loc }}

Revenue at risk

DOB

Patient ID

Referral

Therapy

Insurance

Deductible

Out-of-pocket max

Copay / assistance

Prior & active authorizations

Clinical documents

Detected risk

Evidence Assura found

Action {{ D.action }}

{{ dAssignInits }}Assigned to{{ dAssignFull }}

Unassignedready to assign

Owner · {{ D.owner }}Urgency · {{ D.urgency }}

The queue becomes a financial decision system.

How Assura works

Detect, quantify, enrich, and resolve—one issue at a time.

{{ curWi }} Illustrative

S. Whitfield · Infliximab Jul 12

Coverage terminated · authorization tied to inactive plan

Revenue at risk $18,420

Evidence attached

Active coverage, Jul 1 Preferred biosimilar rule Clinical documentation

Submit authorization for the preferred product Owner · Patient access · 18 min

Not another alert. A solvable piece of work.

Assura does not ask your team to investigate an alert from scratch. It organizes the evidence, explains the risk, and makes the next action explicit.

Critical · $18,420 revenue at risk Appointment in 4 days

Resolved · $18,420 protected Appointment retained

Patient

Sarah Whitfield

Therapy

Infliximab (Avsola)

Scheduled

Jul 12, 9:30 AM

Site

Brooklyn infusion suite

Outcome

✓Authorization approved for the preferred product

✓Appointment retained on schedule

✓$18,420 revenue protected

Why Assura flagged it

Coverage on file terminated June 30. The existing authorization is tied to the terminated plan.

What Assura found

◆Active commercial coverage effective July 1, with new member and group information

◆Payer requires preferred biosimilar Product B under the medical benefit

◆Prior authorization required; relevant clinical documentation identified in the chart

Recommended actions

1Confirm and update active coverage

2Submit authorization for Product B using attached documentation

3Update the drug-order workflow after approval

Owner · Patient accessEstimated work · 18 minSubmit by · Today

Protect revenue before service. Recover it after.

Before service

Upcoming appointments

·Referral incompleteness

·Inactive or incorrect insurance

·Benefit-path ambiguity

·Prior-authorization gaps

·Drug and biosimilar changes

·Site-of-care restrictions

·Authorization expiration

·Patient-assistance opportunities

OutcomeMore scheduled treatments proceed with the right coverage, approval, product, and financial plan in place.

After service

Performed appointments

·Charge-capture gaps

·Drug-unit inconsistency

·Authorization-to-claim mismatch

·NDC and product issues

·Denials

·Underpayments

·Missing documentation

·Unresolved patient responsibility

OutcomeHigher-value claims receive attention earlier, with a clearer path to correction, appeal, or collection.

Assura follows the financial risk—not an arbitrary boundary between patient access and billing.

Your practice is not a template

The workflow should fit the practice—not the other way around.

The same risk can require a different response depending on your payer mix, drug portfolio, staffing model, locations, technology, and ownership structure.

Assura works with your team to understand:

→Where each workflow begins

→Which systems hold the evidence

→How work is currently assigned

→Which exceptions matter most

→How your practice defines urgency

→What "resolved" means operationally

Operator-led setup

People who understand specialty access and revenue workflows map the practice with your team.

Practice-specific intelligence

Risk rules, priorities, and actions reflect your payer mix, therapies, and operating model.

High-velocity iteration

Assura is refined around the work your team actually encounters—not a generic product roadmap.

Aligned to the revenue outcome—not just software usage.

Assura combines a platform fee with performance-based economics tied to revenue protected or recovered. The goal is straightforward: prioritize the work with the greatest financial consequence, help the team resolve it, and measure the outcome.

Risk identified→ Action resolved→ Appointment retained / claim corrected→ Revenue protected

Example categories

Prevented cancellation Authorization corrected Denial overturned Underpayment recovered Patient assistance secured

Built with the operators doing the work

Show us where revenue risk becomes hardest to see.

We are speaking with rheumatology and infusion leaders to understand where revenue exposure appears first, how teams prioritize it today, and which actions would create the most immediate value.

We will come prepared to map the workflow—not deliver a generic sales pitch.

30 minutes. No generic demo.
A focused conversation about one part of your referral-to-payment process.

✓

Thank you.

We'll follow up to find a useful time.